Saliogen Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Saliogen Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $132 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Saliogen Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2020

SEC CIK1845309

What does Saliogen Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $132.2 million sold (2022).

Frequently asked questions about Saliogen Therapeutics

Where is Saliogen Therapeutics headquartered?

Saliogen Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Saliogen Therapeutics do?

Saliogen Therapeutics, Inc. is a biotechnology company.

When was Saliogen Therapeutics founded?

The earliest incorporation on record for Saliogen Therapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences